The next FinnGen Face-to-Face meeting will be organized 11 - 12 September in Helsinki. 

With this new animation we hope to be able to explain all the essential characteristics of the FinnGen study in a way that is both entertaining and enlightening.

HELSINKI, Finland, January 22, 2019

GSK and Sanofi have joined the FinnGen study, a large public private partnership aiming to collect and analyse genome and health data from 500 000 Finns and thereby generate novel medically and therapeutically relevant insights.

Several FinnGen researchers are participating in the ASHG 2018 meeting.

The next FinnGen Face-to-Face meeting will be organized 24 - 25 October 2018 in Helsinki. 

A unique study that combines genome information with digital health care data has been launched in Finland. The FinnGen study plans to analyse up to 500 000 unique blood samples collected by a nation-wide network of Finnish biobanks. The goal is to deepen our understanding about the origins of diseases and their treatment. The project is expected to continue for six years, with a current budget of €59M.

A unique study has been launched in Finland that will deepen our understanding about the origins of diseases and their treatment. The FinnGen study plans to tap into 500 000 unique blood samples collected by a nation-wide network of Finnish biobanks.